Cardiovascular diseases account for approximately 30% of deaths worldwide and remain a leading cause of morbidity and ...
BACKGROUND: Classically, hypertrophic cardiomyopathy (HCM) has been viewed as a single-gene (monogenic) disease caused by ...
Happy 100th Birthday AHA! It is possible to image the moving heart after all. 2024 is the 70th anniversary of ...
Background: In severely symptomatic patients with obstructive hypertrophic cardiomyopathy (HCM), VALOR-HCM trial (Study to Evaluate Mavacamten in Adults With Symptomatic Obstructive HCM Who Are ...
Pitfalls of Choosing a Study End Point Including Cardiovascular Death in Comparative Clinical Trials
View all available purchase options and get full access to this article.
Cardiac electrophysiology (EP) is a relatively young field. The first surgical ablation of an accessory pathway and the first ...
The EF-hand Ca 2+ sensor protein S100A1 has been identified as a molecular regulator and enhancer of cardiac performance. The ability of S100A1 to recognize and modulate the activity of targets such ...
Cardiomyocytes in the adult human heart show a regenerative capacity, with an annual renewal rate of ≈0.5%. Whether this regenerative capacity of human cardiomyocytes is employed in heart failure has ...
View all available purchase options and get full access to this article.
Kawasaki disease (KD), an acute self-limited febrile illness that primarily affects children <5 years old, is the leading cause of acquired heart disease in developed countries, with the potential of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback